170 related articles for article (PubMed ID: 25556956)
21. Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha).
Anastasiadis AG; Ghafar MA; Salomon L; Vacherot F; Benedit P; Chen MW; Shabsigh A; Burchardt M; Chopin DK; Shabsigh R; Buttyan R
J Cancer Res Clin Oncol; 2002 Jul; 128(7):358-62. PubMed ID: 12136249
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia-inducible factor 1 proteomics and diving adaptations in ringed seal.
Johnson P; Elsner R; Zenteno-Savín T
Free Radic Biol Med; 2005 Jul; 39(2):205-12. PubMed ID: 15964512
[TBL] [Abstract][Full Text] [Related]
23. Homodimerization of the PAS-B domains of hypoxia-inducible factors.
Zhu J; Martinez-Yamout M; Cardoso R; Yan J; Love RA; Grodsky N; Brooun A; Dyson HJ
J Phys Chem B; 2012 Jun; 116(23):6960-5. PubMed ID: 22424208
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia-inducible factor-1β (HIF-1β) is upregulated in a HIF-1α-dependent manner in 518A2 human melanoma cells under hypoxic conditions.
Mandl M; Kapeller B; Lieber R; Macfelda K
Biochem Biophys Res Commun; 2013 Apr; 434(1):166-72. PubMed ID: 23541582
[TBL] [Abstract][Full Text] [Related]
25. TRIM28 and β-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers.
Jovčevska I; Zupanec N; Kočevar N; Cesselli D; Podergajs N; Stokin CL; Myers MP; Muyldermans S; Ghassabeh GH; Motaln H; Ruaro ME; Bourkoula E; Turnšek TL; Komel R
PLoS One; 2014; 9(11):e113688. PubMed ID: 25419715
[TBL] [Abstract][Full Text] [Related]
26. Nanobody-based enzyme immunoassay for aflatoxin in agro-products with high tolerance to cosolvent methanol.
He T; Wang Y; Li P; Zhang Q; Lei J; Zhang Z; Ding X; Zhou H; Zhang W
Anal Chem; 2014 Sep; 86(17):8873-80. PubMed ID: 25079057
[TBL] [Abstract][Full Text] [Related]
27. Menadione and ethacrynic acid inhibit the hypoxia-inducible factor (HIF) pathway by disrupting HIF-1α interaction with p300.
Na YR; Han KC; Park H; Yang EG
Biochem Biophys Res Commun; 2013 May; 434(4):879-84. PubMed ID: 23618863
[TBL] [Abstract][Full Text] [Related]
28. Cloning of hypoxia-inducible factor 1alpha cDNA from a high hypoxia tolerant mammal-plateau pika (Ochotona curzoniae).
Zhao TB; Ning HX; Zhu SS; Sun P; Xu SX; Chang ZJ; Zhao XQ
Biochem Biophys Res Commun; 2004 Apr; 316(2):565-72. PubMed ID: 15020255
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia-inducible factor-1 up-regulates the expression of Toll-like receptor 4 in pancreatic cancer cells under hypoxic conditions.
Fan P; Zhang JJ; Wang B; Wu HQ; Zhou SX; Wang CY; Zhang JH; Tian Y; Wu HS
Pancreatology; 2012; 12(2):170-8. PubMed ID: 22487528
[TBL] [Abstract][Full Text] [Related]
30. MgcRacGAP, a cytoskeleton regulator, inhibits HIF-1 transcriptional activity by blocking its dimerization.
Lyberopoulou A; Mylonis I; Papachristos G; Sagris D; Kalousi A; Befani C; Liakos P; Simos G; Georgatsou E
Biochim Biophys Acta; 2013 Jun; 1833(6):1378-87. PubMed ID: 23458834
[TBL] [Abstract][Full Text] [Related]
31. A nanobody directed to a functional epitope on VEGF, as a novel strategy for cancer treatment.
Farajpour Z; Rahbarizadeh F; Kazemi B; Ahmadvand D
Biochem Biophys Res Commun; 2014 Mar; 446(1):132-6. PubMed ID: 24569074
[TBL] [Abstract][Full Text] [Related]
32. A model for the complex between the hypoxia-inducible factor-1 (HIF-1) and its consensus DNA sequence.
Michel G; Minet E; Ernest I; Roland I; Durant F; Remacle J; Michiels C
J Biomol Struct Dyn; 2000 Oct; 18(2):169-79. PubMed ID: 11089639
[TBL] [Abstract][Full Text] [Related]
33. Generation and characterization of nanobodies against rhGH expressed as sfGFP fusion protein.
Abbady AQ; Al-Shemali R; Mir Assaad J; Murad H
Gen Comp Endocrinol; 2014 Aug; 204():33-42. PubMed ID: 24859761
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia-inducible factor-1alpha promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts.
Dang DT; Chen F; Gardner LB; Cummins JM; Rago C; Bunz F; Kantsevoy SV; Dang LH
Cancer Res; 2006 Feb; 66(3):1684-936. PubMed ID: 16452228
[TBL] [Abstract][Full Text] [Related]
35. [Genetic cloning and expression of hypoxia inducible factor 1 alpha in high altitude hypoxic adaptation species Tibetan antelope (Pantholops hodgsonii)].
Liu F; Wuren T; Ma L; Yang YZ; Ge RL
Sheng Li Xue Bao; 2011 Dec; 63(6):565-73. PubMed ID: 22193452
[TBL] [Abstract][Full Text] [Related]
36. Cloning of hypoxia-inducible factor 1alpha cDNA from chick embryonic ventricular myocytes.
Takahashi T; Sugishita Y; Nojiri T; Shimizu T; Yao A; Kinugawa K; Harada K; Nagai R
Biochem Biophys Res Commun; 2001 Mar; 281(4):1057-62. PubMed ID: 11237772
[TBL] [Abstract][Full Text] [Related]
37. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU
Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362
[TBL] [Abstract][Full Text] [Related]
38. Construction of recombinant adenovirus vector containing a modified gene that codes for human hypoxia-inducible factor-1alpha without oxygen-dependent degradation domain.
Wei L; Lu J; Feng L; Li S; Shan J; Li Y
Plasmid; 2010 Jan; 63(1):20-6. PubMed ID: 19766670
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia-inducible factor-1 in human breast and prostate cancer.
Kimbro KS; Simons JW
Endocr Relat Cancer; 2006 Sep; 13(3):739-49. PubMed ID: 16954428
[TBL] [Abstract][Full Text] [Related]
40. Isolation of nanobodies against Xenopus embryonic antigens using immune and non-immune phage display libraries.
Itoh K; Reis AH; Hayhurst A; Sokol SY
PLoS One; 2019; 14(5):e0216083. PubMed ID: 31048885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
